Illumina Ventures portfolio

Illumina Ventures (Venture capital) is known to hold 41 companies, 28 of them startups. 11 of them are hiring now, with 42 open roles. In the last 12 months rounds in the press named it 1 times (1 as the lead). Its companies closed 7 venture rounds in 12 months, raising $75.1M. Most of them work in Cell & Gene Therapy, Drug Discovery, Diagnostic Tests & IVD.

Source: Alion Venture capital Oct 19, 2026
Investments
41
28 of them startups
Hiring now
11
42 open roles
Deals in 12 months
1
1 as the lead
Rounds in 12 months
7
$75.1M raised
Exits
6

Companies Illumina Ventures has invested in

Actym Therapeutics Oncology Therapeutics Series A · this month portfolio pageSep 25
Light Cast Medical AI Venture round · 1 mo ago portfolio pageSep 25
Tagomics Precision Medicine · United States Venture round · 1 mo ago 1 role portfolio pageSep 25
Integrated Biosciences Drug Discovery AI Venture round $68.4M · 2 mo ago 5 roles portfolio pageSep 25
Syntax Bio Cell & Gene Therapy · United States Series A · 3 mo ago portfolio pageSep 25
Hepta Molecular Diagnostics Seed $6.7M · 11 mo ago lead portfolio page, round in the pressNov 6, 2025
Predicta Biosciences Molecular Diagnostics Series A $23.4M · 12 mo ago 1 role portfolio pageSep 25
Infinity Bio Bioinformatics · United States Series A $8M · 16 mo ago lead portfolio page, round in the pressJun 18, 2025
NuCicer United States Venture round $13.8M · 22 mo ago portfolio pageSep 25
Iambic Therapeutics Drug Discovery AI · United States Convertible Note $75k · 2 yr ago portfolio pageSep 25
Genome Medical Holding United States Venture round $75.3M · 2 yr ago portfolio pageSep 25
Robigo Crop Protection · United States Seed $7M · 3 yr ago portfolio pageOct 3
Protillion Biosciences Biologics & Biosimilars · United States Series A $18M · 3 yr ago lead 1 role portfolio page, round in the pressDec 18, 2022
DELFI Diagnostics Diagnostic Tests & IVD · United States Venture round $225M · 4 yr ago 2 roles portfolio pageSep 25
Arima Genomics Genomics & Genetic Testing · United States Series B · 4 yr ago portfolio pageSep 25
Arbor Biotechnologies Synthetic Biology · United States Venture round $215M · 4 yr ago 3 roles portfolio pageSep 25
Castle Biosciences Diagnostic Tests & IVD · United States Convertible Note $2.4M · 6 yr ago portfolio pageSep 25
Ribometrix Venture round $15M · 7 yr ago portfolio pageSep 25
Kallyope Neurology & CNS Therapeutics · United States Venture round $28.1M · 11 yr ago portfolio pageSep 25
SonoThera Cell & Gene Therapy · United States 3 roles portfolio pageSep 25
Pattern Bioscience Diagnostic Tests & IVD · United States 2 roles portfolio pageSep 25
Precede Biosciences Diagnostic Tests & IVD · United States 2 roles portfolio pageSep 25
Alamarbio Bioinformatics portfolio pageSep 25
Allvue Systems Custody & Fund Administration · United States portfolio pageSep 25
Broken String Biosciences Cell & Gene Therapy · United Kingdom portfolio pageSep 25
Bullseye Biosciences Drug Discovery portfolio pageSep 25
CubaseBio Bioinformatics · Sweden portfolio pageSep 25
DeepSeq Drug Discovery · United States portfolio pageSep 25
Fluent BioSciences United States portfolio pageSep 25
Kodikaz Cell & Gene Therapy · United States portfolio pageSep 25
Nanocellect E-learning · United States portfolio pageSep 25
Oncko United States portfolio pageSep 25
Plutonbio United States portfolio pageSep 25
RedShiftBio Drug Discovery · Taiwan portfolio pageSep 25
Serinus Biosciences United States portfolio pageSep 25

Focus

Markets
Cell & Gene Therapy15%
Drug Discovery15%
Diagnostic Tests & IVD15%
Genomics & Genetic Testing12%
Oncology Therapeutics7%
Bioinformatics7%
Drug Discovery AI7%
Molecular Diagnostics7%
Where its companies are
United States61%
United Kingdom2%
Sweden2%
Taiwan2%
Stage of its companies
Venture, series not stated58%
Series A26%
Pre-seed & seed11%
Series B5%

Questions about Illumina Ventures

How many companies has Illumina Ventures invested in?

Illumina Ventures is known to hold 41 companies: 28 startups, and 6 exits so far, read from its own portfolio page and the funding rounds that name it.

Is Illumina Ventures investing now?

Yes: in the last 12 months 1 rounds in the press named Illumina Ventures (1 as the lead), and 0 companies joined its portfolio page in 90 days.

What does Illumina Ventures invest in?

The markets of the companies Illumina Ventures holds: Cell & Gene Therapy (15%), Drug Discovery (15%), Diagnostic Tests & IVD (15%), Genomics & Genetic Testing (12%), Oncology Therapeutics (7%).

Which Illumina Ventures portfolio companies are hiring?

11 companies Illumina Ventures holds are hiring now, with 42 open roles listed on this page.

Who does Illumina Ventures invest alongside?

The investors that hold the most companies together with Illumina Ventures: ARCH Venture Partners, OrbiMed, Menlo Ventures, M Ventures, Better Ventures.

How this page is made

A company counts as a holding when the investor’s own portfolio page links to it, a program’s catalog lists it, or a funding round in the press names the investor. The numbers are rebuilt every night; each company shows where it came from and when it was first seen.

Sources: its portfolio page, read Oct 3; 3 rounds in the press that name it

Illumina Ventures portfolio: 41 known companies. Alion, Oct 19, 2026. https://alion.io/company/illumina-ventures/portfolio

Licence: CC BY-SA 4.0JSON